company background image
OSSR

Össur hfCPSE:OSSR Stock Report

Last Price

kr.40.15

Market Cap

kr.17.0b

7D

-5.3%

1Y

-12.9%

Updated

23 Jan, 2022

Data

Company Financials +
OSSR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health3/6
Dividends0/6

OSSR Stock Overview

Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Össur hf Competitors

Zimmer Biomet Holdings

NYSE:ZBH

US$25.6b

Vincent Medical Holdings

SEHK:1612

HK$614.7m

Dynatronics

NasdaqCM:DYNT

US$16.1m

Price History & Performance

Summary of all time highs, changes and price drops for Össur hf
Historical stock prices
Current Share Pricekr.40.15
52 Week Highkr.49.85
52 Week Lowkr.38.20
Beta0.71
1 Month Change-5.64%
3 Month Change-7.06%
1 Year Change-12.91%
3 Year Change30.36%
5 Year Change67.29%
Change since IPO630.00%

Recent News & Updates

Nov 25
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Today we will run through one way of estimating the intrinsic value of Össur hf. ( CPH:OSSR ) by taking the expected...

Oct 17
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Sep 28
Is Össur hf (CPH:OSSR) A Risky Investment?

Is Össur hf (CPH:OSSR) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Aug 21
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Does the August share price for Össur hf. ( CPH:OSSR ) reflect what it's really worth? Today, we will estimate the...

Shareholder Returns

OSSRDK Medical EquipmentDK Market
7D-5.3%-3.1%-1.4%
1Y-12.9%-3.6%6.9%

Return vs Industry: OSSR underperformed the Danish Medical Equipment industry which returned -3.6% over the past year.

Return vs Market: OSSR underperformed the Danish Market which returned 6.9% over the past year.

Price Volatility

Is OSSR's price volatile compared to industry and market?
OSSR volatility
OSSR Average Weekly Movement4.0%
Medical Equipment Industry Average Movement5.6%
Market Average Movement5.0%
10% most volatile stocks in DK Market10.2%
10% least volatile stocks in DK Market3.1%

Stable Share Price: OSSR is less volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: OSSR's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19713,500Jon Sigurdssonhttps://www.ossur.com

Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers prosthetics products, including artificial limbs and related products for amputees; and lower and upper limb prosthetic components, including feet, knees, hands, fingers, liners, and other components. The company also provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of bone and soft tissue injuries.

Össur hf Fundamentals Summary


Earnings & Revenue

Key profitability statistics from the latest earnings report
OSSR income statement (TTM)
RevenueUS$700.70m
Cost of RevenueUS$256.51m
Gross ProfitUS$444.19m
ExpensesUS$394.34m
EarningsUS$49.85m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Feb 01, 2022

Earnings per share (EPS)0.12
Gross Margin63.39%
Net Profit Margin7.11%
Debt/Equity Ratio55.4%

How did OSSR perform over the long term?

See historical performance and comparison

Valuation

Is Össur hf undervalued compared to its fair value and its price relative to the market?

10.4%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: OSSR (DKK40.15) is trading below our estimate of fair value (DKK44.82)

Significantly Below Fair Value: OSSR is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: OSSR is poor value based on its PE Ratio (51.8x) compared to the Danish Medical Equipment industry average (43x).

PE vs Market: OSSR is poor value based on its PE Ratio (51.8x) compared to the Danish market (16.6x).


Price to Earnings Growth Ratio

PEG Ratio: OSSR is poor value based on its PEG Ratio (2.6x)


Price to Book Ratio

PB vs Industry: OSSR is good value based on its PB Ratio (4.3x) compared to the DK Medical Equipment industry average (9x).


Future Growth

How is Össur hf forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

20.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OSSR's forecast earnings growth (20.3% per year) is above the savings rate (0.1%).

Earnings vs Market: OSSR's earnings (20.3% per year) are forecast to grow faster than the Danish market (8.5% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: OSSR's revenue (7.1% per year) is forecast to grow faster than the Danish market (6.3% per year).

High Growth Revenue: OSSR's revenue (7.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: OSSR's Return on Equity is forecast to be low in 3 years time (13%).


Past Performance

How has Össur hf performed over the past 5 years?

-9.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: OSSR has a large one-off loss of $22.7M impacting its September 30 2021 financial results.

Growing Profit Margin: OSSR's current net profit margins (7.1%) are higher than last year (3.1%).


Past Earnings Growth Analysis

Earnings Trend: OSSR's earnings have declined by 9.8% per year over the past 5 years.

Accelerating Growth: OSSR's earnings growth over the past year (152%) exceeds its 5-year average (-9.8% per year).

Earnings vs Industry: OSSR earnings growth over the past year (152%) exceeded the Medical Equipment industry 45.3%.


Return on Equity

High ROE: OSSR's Return on Equity (8.5%) is considered low.


Financial Health

How is Össur hf's financial position?


Financial Position Analysis

Short Term Liabilities: OSSR's short term assets ($335.0M) exceed its short term liabilities ($200.5M).

Long Term Liabilities: OSSR's short term assets ($335.0M) do not cover its long term liabilities ($441.2M).


Debt to Equity History and Analysis

Debt Level: OSSR's net debt to equity ratio (41.8%) is considered high.

Reducing Debt: OSSR's debt to equity ratio has increased from 36.4% to 55.4% over the past 5 years.

Debt Coverage: OSSR's debt is well covered by operating cash flow (22.8%).

Interest Coverage: OSSR's interest payments on its debt are well covered by EBIT (8.4x coverage).


Balance Sheet


Dividend

What is Össur hf current dividend yield, its reliability and sustainability?

0.48%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate OSSR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OSSR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if OSSR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OSSR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: OSSR is not paying a notable dividend for the Danish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OSSR's dividend in 3 years as they are not forecast to pay a notable one for the Danish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.9yrs

Average management tenure


CEO

Jon Sigurdsson (65 yo)

26yrs

Tenure

US$1,449,000

Compensation

Mr. Jon Sigurdsson serves as CEO & President at Össur hf. He has been the Chief Executive Officer and President of Gibaud SAS since 1996. Mr. Sigurdsson has been Senior Vice President of Procurement at Pro...


CEO Compensation Analysis

Compensation vs Market: Jon's total compensation ($USD1.45M) is about average for companies of similar size in the Danish market ($USD1.38M).

Compensation vs Earnings: Jon's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: OSSR's management team is seasoned and experienced (5.9 years average tenure).


Board Members

Experienced Board: OSSR's board of directors are seasoned and experienced ( 13 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Össur hf.'s employee growth, exchange listings and data sources


Key Information

  • Name: Össur hf.
  • Ticker: OSSR
  • Exchange: CPSE
  • Founded: 1971
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: kr.16.952b
  • Shares outstanding: 422.21m
  • Website: https://www.ossur.com

Number of Employees


Location

  • Össur hf.
  • Grjothals 1-5
  • Reykjavik
  • 110
  • Iceland

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/23 18:02
End of Day Share Price2022/01/21 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.